MLchartDataset catalogue

autologous anti-EBV CAR T cells BRG01

Term · Oncology and biomedicine · MLC-T-ONC-011422

A preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) targeting an Epstein-Barr virus (EBV) protein, with potential immunostimulating and antineoplastic activities. Upon intravenous administration, the autologous anti-EBV CAR T cells BRG01 targets a specific EBV protein expressed on EBV-positive cancer cells and promotes killing of these cancer cells. EBV infection is associated with various cancers and the expression of certain EBV specific proteins plays a key role in tumor cell proliferation and survival.

Table 1. Record
IdentifierMLC-T-ONC-011422
FieldOncology and biomedicine
Synonymsautologous anti-EBV CAR-T cells BRG01
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011422",
  "term": "autologous anti-EBV CAR T cells BRG01",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) targeting an Epstein-Barr virus (EBV) protein, with potential immunostimulating and antineoplastic activities. Upon intravenous administration, the autologous anti-EBV CAR T cells BRG01 targets a specific EBV protein expressed on EBV-positive cancer cells and promotes killing of these cancer cells. EBV infection is associated with various cancers and the expression of certain EBV specific proteins plays a key role in tumor cell proliferation and survival.",
  "synonyms": [
    "autologous anti-EBV CAR-T cells BRG01"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-anti-ebv-car-t-cells-brg01/"
}

Record 2,754 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.